Wikidata

(Q61921775)

English

Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes

clinical trial

In more languages

Statements

title
Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of MBX-2044 to Evaluate the Multiple-dose Pharmacokinetics, Safety and Tolerability When Administered Orally in Patients With Type 2 Diabetes (English)
0 references
start time
October 2006
0 references
end time
August 2007
0 references
number of participants
60
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61921775&oldid=2103842597"